HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development
作者： Atefeh Arab , Rezvan Yazdian-Robati , Javad Behravan
DOI: 10.1007/S00005-019-00566-1
关键词:
摘要: … HER2-derived peptide vaccines for active immunotherapy. Here, we discuss the development of various HER2-… , other immunotherapeutic approaches to HER2 breast cancer including, …
springer.com
scilit.net参考文章(153)
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
Fateme Sadri-Ardalani, Mahdi Shabani, Mohammad Mehdi Amiri, Motahareh Bahadori, Shaghayegh Emami, Ali Reza Sarrafzadeh, Farzaneh Noutash-Haghighat, Mahmood Jeddi-Tehrani, Fazel Shokri, Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization. Tumor Biology. ,vol. 37, pp. 1217- 1227 ,(2016) , 10.1007/S13277-015-3897-X
J. Janseens, L. Opdebeek, J. Raus, J. Vandenbrande, J. Vandepitte, Ying Chin, Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Research. ,vol. 12, pp. 1463- 1466 ,(1992)
Javad Behravan, Fatemeh Mosaffa, Hermann Lage, Khalil Abnous, Ali Badiee, Mahmoud Reza Jaafari, Mahnaz Nourbakhsh, Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer Iranian Journal of Basic Medical Sciences. ,vol. 18, pp. 385- 392 ,(2015) , 10.22038/IJBMS.2015.4288
Edward F McCarthy, The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. The Iowa orthopaedic journal. ,vol. 26, pp. 154- 158 ,(2006)
I Yoshino, T J Eberlein, A S Parikh, G E Peoples, P S Goedegebuure, H K Lyerly, A F Gazdar, J M DiMaio, HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Research. ,vol. 54, pp. 3387- 3390 ,(1994)
Angela R. Winnier, Angela R. Winnier, Carlos L. Arteaga, Stephen D. Hurd, Stanford J. Stewart, Laura K. Shawver, Miriam C. Poirier, Daniel M. Lopez-Larraza, p185c-erbB-2 signaling enhances cisplatin-induced cytotoxicity in human breast carcinoma cells : association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair Cancer Research. ,vol. 54, pp. 3758- 3765 ,(1994)
Jack R. Wands, Byron Wilson, Kurt J. Isselbacher, William Strauss, Hiroshi Takahashi, Philippe Motté, Mehmet Ozturk, In vivo localization of human colon adenocarcinoma by monoclonal antibody binding to a highly expressed cell surface antigen. Cancer Research. ,vol. 48, pp. 6573- 6579 ,(1988)
Roger Moe, Mary L. Disis, Ann E. Murphy, Robert B. Livingston, Margit Jeschke, Elaine McGlynn, Wei Chen, Martin A. Cheever, Emanuel Calenoff, Graham McLaughlin, Nick Lydon, Bernd Groner, Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Research. ,vol. 54, pp. 16- 20 ,(1994)
Olivera J. Finn, Nieves Domenech, Keith R. Jerome, Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. Journal of Immunology. ,vol. 151, pp. 1654- 1662 ,(1993)